The Wound Institute today announced it has been named a 2012 Gold Award Winner in the 14th annual Web Health Awards[SM] for its online Medical Education platform developed for healthcare professionals. Additionally, The Wound Institute Patient Portal, which provides educational resources designed for patients and caregivers, received a Merit Award.
|
Mon, 08/13/2012
|
||
Fri, 08/03/2012
Healthpoint Biotherapeutics today announced that the results for its Phase 2b clinical trial investigating the efficacy of HP802-247 in venous leg ulcers is published on The Lancet, beginning August 3, 2012, with Online First access to the article, followed by print publication in the next issue. HP802-247 is an investigational allogeneic living cell bioformulation containing keratinocytes and fibroblasts currently under development for the treatment of venous leg ulcers. |
||
Wed, 07/25/2012
Healthpoint Biotherapeutics today announced that the results of a 24-week open-label follow-up to the HP802-247 Phase 2b trial will be presented by Robert Kirsner, MD, PhD, on Friday, July 27, 2012, from 3:55- 4:15 pm, during the American College of Wound Healing and Tissue Repair held at the Swissotel in Chicago. |
||
|
Wed, 06/20/2012
Healthpoint Biotherapeutics today announced the company is planning a significant upgrade to its 80,000 square foot research and manufacturing facility in Ft. Worth. The new, state-of-the-art facilities will comprise 25,000 square feet of manufacturing infrastructure, labs and clean room space for the production of cell-based therapies. |
||
|
Mon, 06/11/2012
The Wound Institute today announced the launch of a new educational module “Guide to Chronic Wound Care,” an accredited, online course designed to help primary care physicians, podiatrists, nurses, physical therapists, pharmacists and other healthcare professionals involved in treatment of patients with difficult to heal wounds. |
